REFINE PHARMA LTD

Active Bolton

Manufacture of pharmaceutical preparations

9 employees website.com
Lifestyle and entertainment Manufacture of pharmaceutical preparations
R

REFINE PHARMA LTD

Manufacture of pharmaceutical preparations

Founded 8 Nov 2021 Active Bolton, England 9 employees website.com
Lifestyle and entertainment Manufacture of pharmaceutical preparations

Previous Company Names

BJ PHARMA (UK) LTD 8 Nov 2021 — 19 Feb 2025
Accounts Due 31 Aug 2026 3 months remaining
Confirmation Submitted 22 Jan 2026 Next due 5 Feb 2027 9 months remaining
Net assets £329K £187K 2024 year on year
Total assets £2M £263K 2024 year on year
Total Liabilities £2M £450K 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

80 St. Georges Road Bolton BL1 2DD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for REFINE PHARMA LTD (13729940), an active lifestyle and entertainment company based in Bolton, England. Incorporated 8 Nov 2021. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£379.05k

Increased by £210.48k (+125%)

Net Assets

£328.63k

Increased by £186.80k (+132%)

Total Liabilities

£1.61M

Decreased by £450.02k (-22%)

Turnover

N/A

Employees

9

Increased by 2 (+29%)

Debt Ratio

83%

Decreased by 11 (-12%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Bradley Steve TysonDirectorBritishEngland3015 Mar 2023Active
Refine Group Holdings LimitedCorporate-directorUnknownUnknown2 Feb 2023Active

Shareholders

Shareholders (2)

Refine Bs Holdings Limited
100.0%
2
Bradley Tyson
0.0%
0

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Refine Bs Holdings Limited

Unknown

Active
Notified 22 Jan 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Bradley Tyson

British

Active
Notified 8 Nov 2021
Residence England
DOB October 1995
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Jarnail Singh Kang

British

Active
Notified 8 Nov 2021
Residence England
DOB March 1967
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

REFINE PHARMA LTD Current Company
KBAL LTD united kingdom
LMBJ LIMITED united kingdom

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026OfficersChange Corporate Director Company With Change Date
26 Feb 2026Persons With Significant ControlChange to Refine Bs Holdings Limited as a person with significant control on 26 Feb 2026
22 Jan 2026Confirmation StatementConfirmation statement made on 22 Jan 2026 with updates
22 Jan 2026Persons With Significant ControlCessation of Bradley Tyson as a person with significant control on 22 Jan 2026
22 Jan 2026Persons With Significant ControlRefine Bs Holdings Limited notified as a person with significant control
26 Feb 2026 Officers

Change Corporate Director Company With Change Date

26 Feb 2026 Persons With Significant Control

Change to Refine Bs Holdings Limited as a person with significant control on 26 Feb 2026

22 Jan 2026 Confirmation Statement

Confirmation statement made on 22 Jan 2026 with updates

22 Jan 2026 Persons With Significant Control

Cessation of Bradley Tyson as a person with significant control on 22 Jan 2026

22 Jan 2026 Persons With Significant Control

Refine Bs Holdings Limited notified as a person with significant control

Recent Activity

Latest Activity

Change Corporate Director Company With Change Date

2 months ago on 26 Feb 2026

Change to Refine Bs Holdings Limited as a person with significant control on 26 Feb 2026

2 months ago on 26 Feb 2026

Confirmation statement made on 22 Jan 2026 with updates

3 months ago on 22 Jan 2026

Cessation of Bradley Tyson as a person with significant control on 22 Jan 2026

3 months ago on 22 Jan 2026

Refine Bs Holdings Limited notified as a person with significant control

3 months ago on 22 Jan 2026